Contrast-enhanced in-phase Dixon sequence could reduce the need for correlation among other imaging modalities to better identify areas of prior biopsy during breast MRI interpretation, according to a ...
MRI contrast agents, which are typically gadolinium-based, are used to enhance visualization of abnormal structures or lesions and to aid differentiation between healthy and pathological tissue. This ...
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Employing this contrast-enhanced in-phase Dixon sequence may "help address a current challenge in routine clinical breast MRI interpretation," the authors of this AJR article concluded. Taylor-Cho, ...
Bayer to present new phase III data and advancements of radiology portfolio at ECR 2026: Berlin Wednesday, January 28, 2026, 13:00 Hrs [IST] Bayer will present advancements of its ...
Leesburg, VA, September 14, 2022—According to ARRS’ American Journal of Roentgenology (AJR), the contrast-enhanced in-phase Dixon sequence could reduce the need for correlation among other imaging ...
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results